LaQuanda Turner

Evaluated business plans for SHCS hospitals and secondary site locations; analyzed strategic, financial, and operational aspects and evaluated accuracy and likelihood of success. Organized business development assessment process, overseeing internal and external review for financial/accounting, clinical, operations, marketing, legal, reimbursement, regulatory and compliance, and information technology; led due diligence.

At leadership’s direction, orchestrated broad institutional support and stakeholder input for major initiatives. Established exchanges with key organizations and device manufacturers to gain market intelligence needed in planning for evolving needs of healthcare consumers. Targeted select opportunities in the business units for pro formas and decision support modeling that guided strategic and operational decision making. Retained pipeline of long-term solutions based on opportunities.

• Translated business goals and objectives into concrete strategy and tactical plans in partnership with Hospital Presidents and their local communities.
• Reduced operating costs 35% through new methodologies to streamline operating processes.
• Identified strategic new business opportunities through granulated market analysis and aggressive go-to market strategies.

Oversaw corporate compliance programs and projects, their development, and ongoing management. Administered internal compliance audits in addition to periodic monitoring reviews to identify gaps in adherence to company and HIPAA privacy policies and procedures. Collaborated with deficient departments on corrective action plans. Devised formal audit chain documentation, reporting, and oversight. Partnered with Clinical Staff on product changes; scheduled training for compliance and privacy aspects of new products and services.

• Fostered compliance culture and established positive working relationships with regulators.
• Advised clinical and business leadership on cost versus patient care issues and product and service requirements list.
• Mitigated corporate risk and liability through increased flexibility added to standard contract terms.
• Coordinated revisions to network contract tiers and pricing with Group Purchasing Organizations (GPO’s) this garnered a net savings of 6.26% per month.
• Project managed introduction of new Regulatory Compliance program for Integrated Waste Streams that included Municipal Solid (MSW), Regulated Medical (RMW) and Hazardous Waste in addition to disposal of confidential documents. This streamline process netted a 14% overall co
• Implemented quarterly onsite audits for the 4 divisions of the Health System to improve compliance issues and concerns.

Oversaw analytics for global Fortune 500 key accounts to ensure customer service efficiencies, quality standards, and performance guarantees were achieved. Initiated targeted market research studies; analyzed third-party data findings. Verified accuracy of shipping documentation for deliveries and returned goods. Directed company adoption of Industry Best Practices in supply chain operations.

• Reconciled $24M across the Rx, Generic, and Non-Rx categories of the National Buying Center.
• Negotiated $2.5M in monthly pharmaceutical product inventory returns and sell-through.
• Led efforts that established strategic sourcing capabilities for McKesson’s 26 Distribution Centers.
• Devised Supply Chain metrics for service, financial performance, and reporting.
• Orchestrated inventory removals instigated by FDA-ordered product withdrawals and recalls; verified actions at Distribution Center/Customer level.